The management of idiopathic nephrotic syndrome in children

被引:24
作者
Elisabeth M. Hodson
机构
[1] Centre for Kidney Research, Children's Hospital at Westmead, Sydney, NSW
[2] Centre for Kidney Research, Children's Hospital at Westmead, Westmead, NSW 2145
基金
英国医学研究理事会;
关键词
Cyclosporine; Nephrotic Syndrome; Corticosteroid Therapy; Atrial Natriuretic Peptide; Levamisole;
D O I
10.2165/00128072-200305050-00006
中图分类号
学科分类号
摘要
Childhood nephrotic syndrome is a rare condition with an incidence of 1-2 per 100 000 children aged below 16 years. Untreated idiopathic nephrotic syndrome (INS) is associated with increased risks of life-threatening infection, thromboembolism, lipid abnormalities, and malnutrition. The aim of the management of INS in children is to induce and maintain complete remission with resolution of proteinuria and edema without serious adverse effects of therapy. The majority of children have corticosteroid sensitive idiopathic nephrotic syndrome (CSINS), and in these children, corticosteroid therapy is the mainstay of therapy to induce remission. Data from a meta-analysis of randomized controlled trials (RCTs) indicate that prolonged courses of corticosteroids (up to 7 months) given in the first episode of CSINS reduce the risk of relapse. Nevertheless, many children relapse, and are at risk of corticosteroid toxicity if frequent courses of corticosteroids are required. Data from RCTs supports the use of alkylating agents (cyclophosphamide, chlorambucil), cyclosporine, and levamisole in these children to achieve prolonged periods of remission. The specific management of corticosteroid-resistant idiopathic nephrotic syndrome (CRINS) is more difficult since few therapies are consistently effective, and data from RCTs are limited. In such children, cyclosporine, alkylating agents, and high dose intravenous methylprednisone may be used. In addition to specific therapies for INS, supportive therapies are commonly used to control edema (loop diuretics, aldosterone antagonists, albumin infusions, angiotensin-converting enzyme inhibitors), reduce the risk of infection (antibacterials, pneumococcal vaccination) and thromboembolism (aspirin [acetylsalicylic acid]), and to control hyperlipidemia (HMG-CoA reductase inhibitors), especially in children with CRINS.
引用
收藏
页码:335 / 349
页数:14
相关论文
共 106 条
[1]  
Schlesinger E.R., Sultz H.A., Mosher W.E., Et al., The nephrotic syndrome: Its incidence and implications for the community, Am J Dis Child, 116, pp. 623-632, (1968)
[2]  
McKinney P.A., Feltbower R.G., Brocklebank J.T., Et al., Time trends and ethnic patterns of childhood nephrotic syndrome in Yorkshire, UK, Pediatr Nephrol, 16, pp. 1040-1044, (2001)
[3]  
Hodson E.M., Willis N.S., Craig J.C., Incidence of nephrotic syndrome in children in Australia, Seventh Asian Congress of Pediatric Nephrology, (2000)
[4]  
Srivastava T., Simon S.D., Alon U.S., High incidence of focal and segmental glomerulosclerosis in nephrotic syndrome of childhood, Pediatr Nephrol, 13, pp. 13-18, (1999)
[5]  
Nephrotic syndrome in children: Prediction of histology from clinical and laboratory characteristics at time of diagnosis, Kidney Int, 13, pp. 159-165, (1978)
[6]  
Primary nephrotic syndrome in children: Clinical significance of histopathologic variants of minimal change and of diffuse mesangial proliferation, Kidney Int, 20, pp. 765-771, (1981)
[7]  
Bhimma R., Coovadia H.M., Adhikari M., Nephrotic syndrome in South African children: Changing perspectives over 20 years, Pediatr Nephrol, 11, pp. 429-434, (1997)
[8]  
The primary nephrotic syndrome in children: Identification of patients with minimal change nephrotic syndrome from initial response to prednisone, J Pediatr, 98, pp. 561-564, (1981)
[9]  
Cattran D.C., Rao P., Long-term outcome in children and adults with classic focal and segmental glomerulosclerosis, Am J Kid Dis, 32, pp. 72-79, (1998)
[10]  
Consensus statement on management and audit potential for corticosteroid responsive nephrotic syndrome. Report of a workshop by the British Association for Paediatric Nephrology and Research Unit, Royal College of Physicians, Arch Dis Child, 70, pp. 151-157, (1994)